Blog

Yuriko Nakao/Getty Images

SAN FRANCISCO, June 10, 2021 /PRNewswire/ — The global durable medical equipment rental market size is expected to reach USD 35.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.8% from 2021 to 2028. The growth is attributable to financial benefits offered by renting durable medical equipment (DME) as it aids in bridging the gap between capital availability and clinical needs. Moreover, before buying, renting DME helps in determining whether or not they are a suitable fit.Key suggestions from the report:The bathroom safety and medical furniture segment accounted for the largest revenue share of 56.4% in 2020 owing to growing technological innovations in such medical equipmentThe hospitals’ segment accounted for the largest revenue share of 59.2% in 2020 owing to huge patient footfall in comparison to laboratories and institutes coupled with growing need to keep up with technological advancementsNorth America contributed for the largest revenue share of 32.5% owing to the presence of dominant market players, high healthcare expenditure, and high adoption rate for advanced medical technologiesRead 187 page research report with ToC on “Durable Medical Equipment Rental Market Size, Share & Trends Analysis Report By Application, By End-use (Personal/Home Care, Institutes & Laboratories, Hospitals), By Region, And Segment Forecasts, 2021 – 2028” at:https://www.grandviewresearch.com/industry-analysis/durable-medical-equipment-rental-marketThe COVID-19 pandemic has disrupted the supply chains of various medical devices. The shelter-in-place mandates have led to a shortage in the workforce across the supply chain industry. However, there has been a sudden surge in the demand for respiratory equipment owing to the ongoing coronavirus pandemic. The DME rental players are fulfilling these demands for hospitals as well as home care patients. Looking at the short-term necessity of these products, and to boost sales, various local manufacturers have come up with a marketing strategy that involves renting out this equipment. Therefore, the market for DME rental is projected to grow with a lucrative CAGR during the pandemic crisis.The rising number of people with disabilities across the globe is boosting the demand for wheelchairs, crutches, walkers, and other such personal mobility equipment and aids. This, in turn, boosts the demand for DME rental. According to the WHO, more than a billion people have some form of disability in the world that accounts for around 15% of the global population. Also, there is a rapid increase in the number of people with disabilities owing to rising chronic health conditions and demographic trends. For instance, over 54 million adults have arthritis in the US according to a study by the CDC. This number is projected to cross 78 million by 2040.

The market is also driven by the growing demand for therapeutic and monitoring equipment. This demand is attributable to improving healthcare infrastructure across the globe coupled with continuous technological advancements in durable medical equipment. Renting advanced durable medical equipment helps in keeping up with the changing technology in a cost-effective manner. Moreover, people who need mobility equipment temporarily mostly prefer renting.The rise of financial services for renting DME has been beneficial for various end-users such as hospitals, institutes & laboratories, as well as home care. Moreover, renting equipment confers cost benefits to end-users, as it reduces ownership costs and in turn allows these players to adopt advanced product modules. Medical equipment insurers typically cover around 50% to 80% of the overall cost of durable medical equipment such as a wheelchair. The maintenance and insurance are taken care of by the provider. This, in turn, reduces the risk for end-user and augments the growth of the market.Grand View Research has segmented the global durable medical equipment rental market on the basis of application, end-use, and region:DME Rental Application Outlook (Revenue, USD Billion, 2016 – 2028)Personal Mobility Devices Bathroom Safety and Medical Furniture Monitoring and Therapeutic DevicesDME Rental End-use Outlook (Revenue, USD Billion, 2016 – 2028)Personal/Home care Institutes and laboratories HospitalsDME Rental Regional Outlook (Revenue, USD Billion, 2016 – 2028)North AmericaU.S. CanadaEuropeU.K. GermanyFranceItalySpainAsia PacificChinaJapanIndiaAustraliaSouth KoreaLatin AmericaBrazilMexicoMiddle East & AfricaSouth AfricaUAEList of Key Players of Durable Medical Equipment (DME) Rental MarketHill-Rom Holdings, Inc. Siemens Financial Services, Inc. Nunn’s Home Medical Equipment Westside Medical Supply Universal Hospital Services, Inc. Woodley Equipment Company Ltd. C.N.Y Medical Products Inc. All American Medical Supply Corp. Homepro Medical Supplies, LLCFind more research reports onMedical Devices Industry, by Grand View Research:

U.S. Durable Medical Equipment Market– The U.S. durable medical equipment market size is expected to reach USD 84.3 billion by 2028. Increasing penetration of home healthcare services & staff are factors driving the demand for durable medical equipment. Personal Mobility Devices Market– The global personal mobility devices market size is expected to reach USD 18.2 billion by 2028.Growing product development and rising number of accidents causing disabilities are some of the key factors driving the market. Long Term Care Market– The global long term care market size is expected to reach USD 1.7 trillion by 2027. The market for long term care is expected to boom owing to aging baby boomers and increasing disabilities among the geriatric population.Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reportsAbout Grand View ResearchGrand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.Contact:Sherry JamesCorporate Sales Specialist, USAGrand View Research, Inc.Phone: 1-415-349-0058Toll Free: 1-888-202-9519Email: sales@grandviewresearch.com   Web: https://www.grandviewresearch.com   Follow Us: LinkedIn | Twitter View original content:https://www.prnewswire.com/news-releases/durable-medical-equipment-rental-market-size-worth-35-4-billion-by-2028-grand-view-research-inc-301309711.html

SOURCE Grand View Research, Inc.

HELSINKI, June 10, 2021 /PRNewswire/ — Valmet has on June 9, 2021, entered into agreements to acquire EWK Umwelttechnik GmbH, a German company manufacturing and supplying air emission control systems and after-installation services, and ECP Group, a Finnish manufacturer and maintainer of air emission control systems. These acquisitions complement Valmet’s customer offering in environmental technologies and related services.  The values of the acquisitions will not be disclosed. The acquisitions are estimated to be completed in July 2021. After the acquisitions are completed, Valmet’s Environmental Systems offering covers technologies and services for wet and dry flue gas cleaning, flue gas desulfurization, NOx reduction and burner systems for energy and process industries, and marine scrubbers. The acquisition of EWK Umwelttechnik EWK Umwelttechnik’s offering of emission control technologies includes electrostatic precipitators, wet absorbers, catalytic and heat recovery systems, and wastewater purification products. The company serves multiple customer segments, including wood-based panelboard, glass, mineral wool, and steel industries.The net sales of EWK Umwelttechnik were approximately EUR 22 million in 2020. The company, founded in 1868, is based in Kaiserslautern, Germany, and employs approximately 50 employees.

“This acquisition is an excellent strategic fit for Valmet and our technology and services offering enhancing our customers’ environmental performance. The tightening emission regulations and strive for sustainable technology is increasing the demand for various air emission control solutions across industries. Integrating EWK Umwelttechnik’s offering to Valmet’s offering strengthens our environmental systems business by complementing our existing technology offering especially in the area of wet and dry electrostatic precipitators and in water treatment technology as well as widening the industries that our emission control technologies cover. EWK Umwelttechnik has a very skilled team and I am happy to warmly welcome them to become part of Valmet,” says Bertel Karlstedt, Business Line President, Pulp and Energy, Valmet.”Both Valmet and EWK have long history in environmental solutions, technology and business. The complementary broad offering of emission control solutions offers good possibilities to widen the scope beyond the current technologies, applications and customer industries, and to continue to serve the customers globally to meet their current and future needs. As an industrial long-term owner Valmet provides EWK and its personnel a solid platform for further development and growth,” says Peter Ohlenschläger, CEO of EWK Umwelttechnik GmbH. The acquisition of ECP GroupECP Group is a manufacturer and maintainer of electrostatic precipitators (ESP), focusing on power plants and pulp and paper industry, in Finland. Company’s offering consists of manufacturing and modernizing electrostatic precipitators as well as providing services, such as inspections, annual maintenance, spare parts and performance improvements. An electrostatic precipitator (ESP) is an air emission control device that removes solid particles from the flue gases generated in combustion processes.The net sales of ECP Group were approximately EUR 6 million in 2020. The company, founded in 2002, is headquartered in Vantaa, Finland, and employs around 20 employees.

“Environmental demands are tightening in all industries, and this development is supporting Valmet and its Environmental Systems business. The acquisition of ECP Group means a step change in our capabilities to offer environmental systems services. Together with ECP Group’s offering and competences, we will enhance our after sales capabilities and are able to serve our customers in improving and maintaining the emission controlling,” says Jussi Sinisalo, Director, Environmental Systems, Pulp and Energy business line, Valmet.VALMET Corporate Communications For further information, please contact:The acquisition of EWK Umwelttechnik:Bertel Karlstedt, Business Line President, Pulp and Energy, Valmet, tel. +358 10 672 0000 Jussi Sinisalo, Director, Environmental Systems, Pulp and Energy, Valmet, tel. +358 40 743 9272Markus Bolhàr-Nordenkampf, Director, Energy Sales & Services Operations, EMEA, Valmet, tel. +43 664 829 4054The acquisition of ECP Group:Jussi Sinisalo, Director, Environmental Systems, Pulp and Energy, Valmet, tel. +358 40 743 9272Minna Saarelainen, Director, Finland and Baltics, Energy Sales and Services Operations, Valmet, tel. +358 40 545 9407  Valmet is the leading global developer and supplier of process technologies, automation and services for the pulp, paper and energy industries. We aim to become the global champion in serving our customers. 

Valmet’s strong technology offering includes pulp mills, tissue, board and paper production lines, as well as power plants for bioenergy production. Our advanced services and automation solutions improve the reliability and performance of our customers’ processes and enhance the effective utilization of raw materials and energy.Valmet’s net sales in 2020 were approximately EUR 3.7 billion. Our 14,000 professionals around the world work close to our customers and are committed to moving our customers’ performance forward – every day. Valmet’s head office is in Espoo, Finland and its shares are listed on the Nasdaq Helsinki.  Read more www.valmet.com, www.twitter.com/valmetglobal Processing of personal dataThis information was brought to you by Cision https://news.cision.com

https://news.cision.com/valmet-oyj/r/valmet-strengthens-its-environmental-systems-business-with-two-acquisitions,c3364457

OSLO, Norway, June 10, 2021 /PRNewswire/ — Aker ASA announced today that Aker Capital (collectively referred to as “Aker”) has acquired the Norwegian technology and research and development (R&D) company Prototech AS (“Prototech”). The acquisition provides access to a portfolio of industrial technology solutions and R&D capabilities that underpin Aker’s strategic development in the energy transition.”Prototech has an impressive portfolio of technologies and expertise that need both capital and active ownership to realize their full potential,” said Øyvind Eriksen, President and CEO at Aker. “Aker has been developing knowledge-based industry for 180 years. There is no shortage of exciting ideas, research, and technology developments happening all over Norway. Identifying and developing interesting companies and investment opportunities is an essential part of the work to drive Aker’s value creation over time. Prototech has R&D capabilities and solutions that we believe can play an important role in Aker’s long-term development.”Prototech, established in 1988, was originally part of the Mechanical Section of the Christian Michelsen Institute (CMI) in Bergen, and is based on an engineering and technology tradition dating back to 1930 when CMI was established as a non-profit R&D institute. Over the last 30 years, Prototech has developed into a R&D and technology company with expertise and a broad portfolio within space applications, new energy systems, and technologies for the offshore and maritime sectors. “Prototech has a long and proud history developing technology for Space and Ocean Space. Our energy solutions are maturing and can potentially make a real difference in the zero-carbon economy. To succeed we need industrial ownership to accelerate our development and provide capital for growth. Aker is the perfect owner for Prototech going forward, and we are very happy to become part of the family,” said Bernt Skeie, CEO at Prototech. Aker has acquired 100 percent of the company from NORCE, one of Norway’s largest independent research institutes owned by several leading Norwegian universities, for an undisclosed amount. As part of the transaction, a new Board of Directors will be constituted, which will include Prototech’s current employee-elected Directors. 

CONTACT: For more information, please contact: Christina Glenn, Head of Corporate Communications and Investor Relations, Aker ASA+47 905 32 774 christina.glenn@akerasa.comBernt Skeie, CEO, Prototech AS+47 950 46 031bernt.skeie@prototech.noThis information was brought to you by Cision https://news.cision.comhttps://news.cision.com/aker-asa/r/aker-asa-signs-agreement-to-acquire-prototech-as,c3364155

CORK, Ireland, June 10, 2021 /PRNewswire/ — Johnson Controls (NYSE: JCI), the global leader for smart, healthy and sustainable buildings, has joined a call to action on the eve of the Group of Seven (G7) Summit in Cornwall, UK. Lending its support to an open letter issued by the Alliance of CEO Climate Leaders, Johnson Controls has urged the G7 and other global leaders to accelerate a just transition in the race to net-zero and climate resilience, calling for bold commitments, policy and actions to avoid the worst impacts of climate change. “Reducing energy waste from buildings also saves money, so there is every reason to accelerate action.”The Alliance, an informal group facilitated by the World Economic Forum, of which Johnson Controls is a member, is the largest community of Chief Executive Officers in the world committed to climate action – representing 21 countries and 13 industries with combined revenues of $2.4 trillion. In its letter to the G7, it states that the current trajectory for greenhouse gas emissions is leading the world to “current and irreversible outcomes”, and says that with just five months to go before COP26 in November, “bold action” across private and public sectors is needed.”There is no time to waste in tackling climate change. Technologies already exist today that can put us solidly on the pathway to net zero by 2050. We know that decarbonization of buildings is part of the solution as buildings represent some 40% of global emissions. Reducing energy waste from buildings also saves money, so there is every reason to accelerate action,” said George Oliver, chairman and CEO, Johnson Controls. “The G7 Summit is a critically important opportunity for wealthy nations to show needed leadership, but it has to be a collective effort. Governments can expedite further action from companies; businesses are ready to move fast and boost investments to create a sustainable future.”The Alliance letter states that its members have made clear commitments and are working to transition their businesses to net-zero. “Greater collaboration between business and government on achieving our net-zero ambitions can help accelerate this process for the benefit of our economies and societies,” it said.

Johnson Controls has already set ambitious emissions reductions targets, which were recently approved by the Science Based Targets Initiative – an independent organization that assesses corporate sustainability claims. As part of its environmental sustainability commitments, Johnson Controls aims to cut operational emissions by 55 percent and reduce customers’ emissions by 16 percent before 2030. Its OpenBlue platform for optimizing building sustainability will be central to fulfilling these goals and ultimately creating an environment for healthy people, healthy places and a healthy planet. The company has also joined the Business Ambition for 1.5°C campaign and is a signatory to The Climate Pledge, an initiative of business leaders co-founded by Amazon and Global Optimism. Signatories to the pledge commit to reaching net zero carbon emissions by 2040 – ten years ahead of the Paris Climate Agreement goal.Johnson Controls is continuing to exercise its leadership in climate action through the Business Roundtable, with George Oliver joining the organization as chair of the Energy & Environment Committee in January. Business Roundtable is an association of chief executive officers of America’s leading companies. Its Energy & Environment Committee is dedicated to advancing policies that encourage innovation and support an environmentally and economically sustainable future. As a leader in the buildings space for more than 135 years, Johnson Controls has been a pioneer in sustainability. It is ranked in the top 12 percent of climate leadership companies globally by CDP and was recently named again to the World’s Most Ethical Companies® Honoree List and one of Corporate Knights’ Global 100 most Sustainable Companies. Click here for full details on the Alliance of CEO Climate Leaders open letter to the G7. To read more about Johnson Controls commitment to sustainability, please visit: https://www.johnsoncontrols.com/corporate-sustainability/environment

About Johnson Controls:At Johnson Controls (NYSE:JCI) we transform the environments where people live, work, learn and play. As the global leader in smart, healthy and sustainable buildings, our mission is to reimagine the performance of buildings to serve people, places and the planet.  With a history of more than 135 years of innovation, Johnson Controls delivers the blueprint of the future for industries such as healthcare, schools, data centers, airports, stadiums, manufacturing and beyond through its comprehensive digital offering OpenBlue. With a global team of 100,000 experts in more than 150 countries, Johnson Controls offers the world`s largest portfolio of building technology, software as well as service solutions with some of the most trusted names in the industry. For more information, visit www.johnsoncontrols.com or follow us @johnsoncontrols on Twitter.INVESTOR CONTACTS:MEDIA CONTACTS:Antonella Franzen

Chaz BickersDirect: 609.720.4665Direct: 224.307.0655 Email: antonella.franzen@jci.comEmail: charles.norman.bickers@jci.com

Ryan EdelmanMichael Isaac Direct: 609.720.4545 Direct: +41 52 6330374Email: ryan.edelman@jci.com  

Email: michael.isaac@jci.com   View original content to download multimedia:https://www.prnewswire.com/news-releases/johnson-controls-supports-call-on-g7-to-speed-up-just-transition-301308946.html

SOURCE Johnson Controls International plc

NEW YORK, June 9, 2021 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of  Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether Oscar and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action]On or around March 3, 2021, Oscar conducted its initial public offering (“IPO”), selling approximately 37 million shares of stock priced at $39.00 per share. Then, on May 13, 2021, Oscar reported its earnings for the first time since the Company’s IPO. Among other results, Oscar reported a loss of $87.4 million, or $0.98 per share, for the first quarter of 2021, compared to analysts estimates that the Company would report a loss of only $0.53 per share. 

On this news, Oscar’s stock price fell $1.63 per share, or 7.36%, to close at $20.51 per share on May 13, 2021.The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.CONTACT:Robert S. WilloughbyPomerantz LLPrswilloughby@pomlaw.com View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-oscar-health-inc—oscr-301309601.htmlSOURCE Pomerantz LLP

SUZHOU, China, June 9, 2021 /PRNewswire/ — Peijia Medical (HKEX:9996, or “Peijia”), a leading player in China for medical technology, announced a partnership with inQB8, a Boston based medical technology incubator, to explore innovative solutions for Structural Heart Disease. This partnership includes Peijia’s acquisition of a transcatheter tricuspid replacement technology (“TTVR”, or “inQB8 TTVR”) from inQB8, which is currently in animal experimental stages and for which the inQB8 team will continue with device development in partnership with Peijia Medical.The partnership combines Peijia’s leadership and technical expertise in structural heart disease and inQB8 team’s strong track record of medical innovation. The arrangement constitutes a 50-50 ownership of the incubator between Peijia and the inQB8 team. In the joint development of novel products and solutions in the structural heart field, Peijia will have exclusive privileges and rights to these technologies globally. InQB8 Medical Technologies is a medical device incubator and the second collaboration between Dr. Arshad Quadri, MD and J. Brent Ratz, MBA, a partnership that began 15 years ago with the co-founding of CardiAQ Valve Technologies, the world’s first trans-septal Transcatheter Mitral Valve Replacement (TMVR) system.  InQB8 focuses on developing new solutions for major cardiovascular diseases including Structural Heart issues, Type A Aortic Dissection and Heart Failure in HFpEF and HFmEF.  InQB8 plans to accelerate projects through prototyping, bench, and pre-clinical testing and allow these early-stage concepts to grow within inQB8 until they are ready to be acquired or advanced as separate stand-alone cardiovascular start-ups. As projects mature, new ideas and concepts will be initiated and developed within the incubator.”inQB8 is proud of its trailblazing efforts in developing breakthrough technologies for the transcatheter treatment of Tricuspid Valve Disease, Type A Aortic Dissection and Heart Failure with preserved or moderately depressed Left Ventricular function. We are excited to be partnering with Peijia Medical to substantially accelerate the development of these projects so that patient needs are met expediently and efficiently. With the support of Peijia Medical, inQB8 is poised to transform the treatment of Structure Heart diseases globally,” said Dr. Arshad Quadri MD, Co-Founder and Executive Chairman of inQB8 Medical Technologies, LLC.As a cardiac surgeon-turned-inventor and entrepreneur, Dr. Quadri brings both clinical insight and an inventor’s creativity to the company. In his clinical practice at St. Francis Hospital in Hartford, CT, USA, he performed an average of 100 to 150 open-heart surgeries per year, was one of the leading implanters of endovascular aortic grafts for aortic aneurysmal disease, and maintained a primary interest in the treatment of ischemic and structural heart disease. In addition to his clinical experiences, Dr. Quadri has a long history of medical innovation. He founded CardiAQ Valve Technology, where he served as Chairman and Chief Medical Officer until it was acquired by Edwards Lifesciences (EW) in 2015 for $350 million, plus milestone payments. Following the acquisition, Arshad joined EW as VP of Medical Affairs TMVR to support and proctor clinical cases in the Early Feasibility Study in the US. Arshad holds 50 granted and published patents. Dr. Quadri is well published in peer-reviewed medical journals, and has presented his work at numerous national and international medical conferences.

“We are thrilled to be working with such an experienced team in Peijia and we see this as an exciting first step in a long-term partnership to drive innovation and support critical patient needs across the globe,” added J. Brent Ratz, inQB8 Co-Founder and Managing Director.Brent Ratz is a successful medical device entrepreneur, executive and inventor with over 20 years of experience in the industry. In addition to his role as Co-Founder and Managing Director of inQB8, he is also the President and CEO of InnovHeart, a second generation TMVR start-up. Previously he was the founding CEO, President and COO of CardiAQ Valve Technologies. Following CardiAQ’s acquisition, Brent joined Edwards Lifesciences as VP R&D TMVR to support the integration, the US Early Feasibility trial, and next generation development. Since leaving EW in 2017, Brent has served as an independent consultant for numerous early-stage device companies and has supported due diligence efforts for several investment funds. “Following the Highlife cooperation, Peijia is now working with yet another high-caliber team for another challenging task that will benefit millions of patients,” said Dr. Yi Zhang, the Chairman and CEO of Peijia Medical. “This shows our commitment to innovation and our ambition to become a global player in the field of transcatheter heart valves. The partnership between Peijia and inQB8 is highly complementary. InQB8 is able to focus on experimenting early ideas while Peijia can further support and propel these ideas to later developmental stages. Peijia retains its entrepreneurial spirit to explore earlier R&D projects. Our values are very aligned with the start-ups and we share a similar mindset with inQB8. That’s why Peijia can do more beyond financing. I believe that through all the various investments and partnerships, Peijia is truly becoming global player with innovative products”. The transaction also involved the acquisition of inQB8 TTVR by Peijia. inQB8’s TTVR system consists of a bio prosthetic valve implant and a customized delivery system. It is designed to be implanted within the native tricuspid valve using a non-surgical, catheter-based approach via trans-jugular or trans-femoral access. The team has already conducted successful acute animal studies with this transcatheter approach and chronic animal studies are currently underwayTricuspid regurgitation (“TR”) is an un-met medical need globally and a serious threat to the patient’s survival. The 5-year survival from the first heart failure is less than 50%. There are almost 50 million patients globally and almost 10 million in China. Less than 1% of Chinese patients receive treatment.”A dedicated transcatheter tricuspid valve replacement technology is desperately needed to treat the large number of patients suffering from tricuspid regurgitation, “according to Dr. Nicolo Piazza, MD, PhD, interventional cardiologist at the McGill University Health Centre. “Given the anatomical characteristics and imaging challenges associated with the tricuspid valve, it may be more suitable for replacement than repair. Having said that, future studies will be needed to better understand optimal patient selection and treatment options. As opposed to simply reassigning a mitral designed device towards the tricuspid valve, inQB8 has started from the ground up and developed a transcatheter tricuspid valve replacement (TTVR) technology that takes into account the critical anatomical details of the tricuspid valve.”   

“Peijia aims to become one of the leading players in Structure Heart globally.” Dr.Zhang commented, “And I expect that a solution to TR, either repair or replacement or maybe both, will be an integral part to any Structure Heart leader’s product portfolio. The acquisition of inQB8’s TTVR will only be the first step for Peijia’s long march towards a truly global medtech company. There will be more novel products in the pipeline of inQB8 to enable Peijia to compete in the most competitive field directly with other multinational medtech companies.  About Peijia MedicalPeijia Medical (09996.HK) was established in 2012 and is headquartered in Suzhou, China. Peijia Medical focuses on the high-growth interventional procedural medical device market in China, and aims to become a world-renowned medical device platform that provides comprehensive treatment solutions for structural heart and neurovascular diseases.Any forward-looking statements are subject to risks and uncertainties such as those described in Peijia Medical’s periodic reports on file with the HKEx. Actual results may differ materially from anticipated results.

(RTTNews) – The Indonesia stock market has alternated between positive and negative finishes through the last four trading days since the end of the six-day winning streak in which it had surged more than 330 points or 6.5 percent. The Jakarta Composite Index now sits just beneath the 6,050-point plateau although it’s likely to tick lower again on Thursday.

The global forecast for the Asian markets is slightly soft ahead of key U.S. inflation data later today. The European markets were mixed and the U.S. bourses were down and the Asian markets figure to split the difference.

The JCI finished modestly higher on Wednesday following gains from the financial shares and resource stocks.

For the day, the index climbed 48.11 points or 0.80 percent to finish at the daily high of 6,047.48 after moving as low as 5,972.45.

Among the actives, Bank Danamon Indonesia advanced 0.87 percent, while Bank CIMB Niaga collected 0.53 percent, Bank Negara Indonesia climbed 1.81 percent, Bank Central Asia gathered 1.56 percent, Bank Mandiri rallied 2.50 percent, Bank Rakyat Indonesia added 0.48 percent, Indosat surged 6.67 percent, Indocement tumbled 1.89 percent, Semen Indonesia spiked 2.21 percent, Indofood Suskes retreated 1.57 percent, United Tractors fell 0.21 percent, Astra International improved 0.95 percent, Astra Agro Lestari rose 0.28 percent, Aneka Tambang soared 4.68 percent, Vale Indonesia jumped 4.35 percent, Timah accelerated 4.35 percent and Bumi Resources and Jasa Marga were unchanged.

The lead from Wall Street suggests mild consolidation as stocks opened mixed on Wednesday, bounced back and forth across the unchanged line and eventually ended slightly lower.

The Dow dropped 152.68 points or 0.44 percent to finish at 34,447.14, while the NASDAQ dipped 13.16 points or 0.09 percent to end at 13,911.75 and the S&P 500 eased 7.71 points or 0.18 percent to close at 4,219.55.

The cautious trade on Wall Street reflected concerns over key inflation data that could prompt the Federal Reserve to begin discussions on tapering its asset buying program sooner than expected.

In economic news, the Commerce Department said wholesale inventories rose 0.8 percent on month to $ 698.0 billion in April after seeing a 1.2 percent increase in March.

Crude oil prices edged lower on Wednesday after data showed a jump in U.S. gasoline stockpiles last week. West Intermediate crude oil futures for July ended down $0.09 or 0.1 percent at $69.96 a barrel.

Closer to home, Indonesia will provide April numbers for retail sales later today; in March, sales plummeted 14.6 percent on year.